Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $67.9M
Liabilities Breakdown FY2020
Total Liabilities: $95.0M
Asset Breakdown
Total Assets: $67.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $18.3M | 26.9% |
| Accounts Receivable | $2.0M | 2.9% |
| Inventory | $13.1M | 19.3% |
| Property, Plant & Equipment | $4.8M | 7.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $29.7M | 43.8% |
Liabilities Breakdown
Total Liabilities: $95.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $13.9M | 14.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $81.0M | 85.3% |